首页> 美国卫生研究院文献>Biology >Tongqiaohuoxue Hinders Development and Progression of Atherosclerosis: A Possible Role in Alzheimer’s Disease
【2h】

Tongqiaohuoxue Hinders Development and Progression of Atherosclerosis: A Possible Role in Alzheimer’s Disease

机译:通桥苏约阻碍了动脉粥样硬化的发展和进展:在阿尔茨海默病中可能的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Alzheimer’s disease and coronary heart disease are two ever-increasing major health concerns worldwide. Scientific studies revealed a link between Alzheimer’s disease and atherosclerosis, a major causality of coronary heart disease. Herbal medicine has been widely prescribed to treat Alzheimer’s disease and atherosclerosis. In the current study, we explored the possible therapeutic effect of Tongqiaohuoxue, a herbal medicine developed during the Qing dynasty of China for the prevention and treatment of cardiovascular disease, on Alzheimer’s disease and atherosclerosis. We discovered Tongqiaohuoxue showed therapeutic effects not only on atherosclerosis but also on Alzheimer’s disease. Tongqiaohuoxue treatment into the animal model of Alzheimer’s disease and atherosclerosis attenuated atherosclerotic plaque and brain amyloid formations, abnormalities that are characteristic of coronary heart disease and Alzheimer’s disease, respectively. Based on these findings, Tongqiaohuxue showed promising therapeutic effects for the treatment of patients with both Alzheimer’s disease and coronary heart disease.
机译:阿尔茨海默病的疾病和冠心病是全世界越来越多的主要健康问题。科学研究揭示了阿尔茨海默病和动脉粥样硬化的联系,冠心病的主要因果关系。草药已被广泛开处方,以治疗阿尔茨海默病和动脉粥样硬化。在目前的研究中,我们探讨了在清代在中国清代制定的草药治疗心血管疾病,对阿尔茨海默病和动脉粥样硬化的治疗中的药物治疗可能的治疗效果。我们发现通桥苏约表明不仅在动脉粥样硬化上表现出治疗效果,也显示出阿尔茨海默病的疾病。通桥苏约治疗阿尔茨海默病和动脉粥样硬化的动物模型,减弱了动脉粥样硬化斑块和脑淀粉样蛋白形成,分别是冠心病和阿尔茨海默病的特征。基于这些发现,通桥展示对Alzheimer疾病和冠心病患者的治疗有前途的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号